α,β-cyclic-β-benzamido hydroxamic acids:: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)

被引:35
|
作者
Ott, Gregory R. [1 ]
Asakawa, Naoyuki [1 ]
Lu, Zhonghui [1 ]
Liu, Rui-Qin [1 ]
Covington, Maryanne B. [1 ]
Vaddi, Krishna [1 ]
Qian, Mingxin [1 ]
Newton, Robert C. [1 ]
Christ, David D. [1 ]
Traskos, James M. [1 ]
James, Carl P. Decicco [1 ]
机构
[1] Bristol Myers Squibb Res & Dev, Dept Discovery Chem & Discovery Biol, Princeton, NJ 08543 USA
关键词
TNF-alpha; tumor necrosis factor-alpha converting enzyme; TACE; matrix metalloproteinase; MMP; beta-amino acid;
D O I
10.1016/j.bmcl.2007.11.059
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Selective inhibitors of TNF-alpha Converting Enzyme (TACE) based on (1R,2S)-cyclopentyl, (3S,4S)-pyrrolidinyl, and (3R,4S)-tetrahydrofuranyl beta-benzamido hydroxamic acids have been synthesized and evaluated. This study has led to the discovery of novel inhibitors whose profiles include activity against TACE in an enzyme assay, potency in the suppression of LPS-stimulated TNF-alpha in human whole blood, selectivity against a panel of MMPs and oral bioavailability. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 50 条
  • [31] Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme
    Wallace, EM
    Moliterni, JA
    Moskal, MA
    Neubert, AD
    Marcopulos, N
    Stamford, LB
    Trapani, AJ
    Savage, P
    Chou, M
    Jeng, AY
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (09) : 1513 - 1523
  • [32] Gelastatins and their hydroxamates as dual functional inhibitors for TNF-α converting enzyme and matrix metalloproteinases:: Synthesis, biological evaluation, and mechanism studies
    Park, SK
    Han, SB
    Lee, K
    Lee, HJ
    Kho, YH
    Chun, H
    Choi, Y
    Yang, JY
    Yoon, YD
    Lee, CW
    Kim, HM
    Choi, HM
    Tae, HS
    Lee, HY
    Nam, KY
    Han, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) : 627 - 634
  • [33] Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-α converting enzyme inhibitors
    Cherney, RJ
    Duan, JJW
    Voss, ME
    Chen, LH
    Wang, L
    Meyer, DT
    Wasserman, ZR
    Hardman, KD
    Liu, RQ
    Covington, MB
    Qian, MX
    Mandlekar, S
    Christ, DD
    Trzaskos, JM
    Newton, RC
    Magolda, RL
    Wexler, RR
    Decicco, CP
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (10) : 1811 - 1823
  • [34] Design and synthesis of remarkably selective, orally bioavaillable inhibitors of tumor necrosis factor-a converting enzyme (TACE):: Discovery of novel benzimidazole P1′ moieties
    Ott, Gregory R.
    Asakawa, Naoyuki
    Lu, Zhonghui
    Anand, Rajan
    Liu, Richard
    Covington, Maryanne
    Vaddi, Krishna
    Qian, Mingxin
    Duan, James J-W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2667 - U2667
  • [35] Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
    Anandan, Sampath-Kumar
    Ward, John S.
    Brokx, Richard D.
    Denny, Trisha
    Bray, Mark R.
    Patel, Dinesh V.
    Xiao, Xiao-Yi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5995 - 5999
  • [36] Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton
    Vu Thi Ha
    Vu Tuan Kien
    Le Huy Binh
    Vu Dinh Tien
    Nguyen Thi Thuy My
    Nguyen Hai Nam
    Baltas, Michael
    Hahn, Hyunggu
    Han, Byung Woo
    Do Thi Thao
    Tran Khac Vu
    BIOORGANIC CHEMISTRY, 2016, 66 : 63 - 71
  • [37] Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Sheppeck, James E., II
    Gilmore, John L.
    Yang, Anle
    Chen, Xiao-Tao
    Xue, Chu-Biao
    Roderick, John
    Liu, Rui-Qin
    Covington, Maryanne B.
    Decicco, Carl P.
    Duan, James J. -W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1413 - 1417
  • [38] Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-α converting enzyme inhibitors
    Letavic, MA
    Barberia, JT
    Carty, TJ
    Hardink, JR
    Liras, J
    Lopresti-Morrow, LL
    Mitchell, PG
    Noe, MC
    Reeves, LM
    Snow, SL
    Stam, EJ
    Sweeney, FJ
    Vaughn, ML
    Yu, CH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3243 - 3246
  • [39] Novel Conjugated Quinazolinone-Based Hydroxamic Acids: Design, Synthesis and Biological Evaluation
    Tran Khac Vu
    Nguyen Thi Thanh
    Nguyen Van Minh
    Nguyen Huong Linh
    Nguyen Thi Phuong Thao
    Truong Thuc Bao Nguyen
    Doan Thi Hien
    Luu Van Chinh
    Ta Hong Duc
    Lai Duc Anh
    Pham-The Hai
    MEDICINAL CHEMISTRY, 2021, 17 (07) : 732 - 749
  • [40] Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors
    Yan, Jiangkun
    Yue, Kairui
    Fan, Xuejing
    Xu, Ximing
    Wang, Jing
    Qin, Mengting
    Zhang, Qianer
    Hou, Xiaohan
    Li, Xiaoyang
    Wang, Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246